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Penicillin-binding protein (PBP) 2 of Escherichia coli is located in the cytoplasmic membrane. The N-termi- 
nal hydrophobic segment (3 1 amino acids, residues 1545) of PBP2 was removed by a deletion in the PBP2 
gene by site-directed mutagenesis, resulting in the production of a water-soluble form of PBP2 (called 
PBP2*). PBP2* retained the penicillin-binding activity, was localized in the cytoplasm and was overpro- 
duced under the control of the fpp-lac promoter. This indicates that the removed hydrophobic segment is 
an uncleaved signal sequence required for translocation of PBP2 across the cytoplasmic membrane, and 
also suggests that the segment anchors the protein to the membrane. 
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1. INTRODUCTION 
Seven penicillin-binding proteins have been 
found in the cytoplasmic membrane of Escherichia 
co/i [l]. Among them, high-molecular-mass PBPs 
(PBPlA [2], PBPlB [3-51, PBP2 [6] and PBP3 
[7]) are bifunctional enzymes showing both 
penicillin-insensitive peptidoglycan transglyco- 
sylase and penicillin-sensitive peptidoglycan 
transpeptidase activities. In the case of PBP2, the 
two activities are detected only in the presence of 
the RodA protein in membrane preparations [6]. 
These PBPs are essential for normal cell growth 
and are the killing targets for penicillin and other 
,&lactam antibiotics. 
The pbpA gene that encodes PBP2 has been 
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cloned [8]. Recently, its nucleotide sequence and 
the deduced amino acid sequence were reported 
[9]. The hydropathy profile of PBP2 suggested 
that a hydrophobic segment close to the N- 
terminus of the protein is the only sequence that 
can span the membrane [9]. Therefore, the N- 
terminal region of PBP2 seems not only an 
uncleaved signal sequence [9] but also an anchor of 
the protein to the cytoplasmic membrane. Thus, 
we attempted to make the protein soluble by 
removing the N-terminal hydrophobic segment 
through a deletion. In this paper, the production 
of a water-soluble form of PBP2 (called PBP2*) 
and its properties are described. 
2. MATERIALS AND METHODS 
2.1. Bacterial strains and plasmids 
E. colt’ MV1184 [ara A(fac-pro) 
480dlacZAM15 A(srl-recA)306::TnlO, 
rpsL thi 
F ’ : traD36 
proAB lacPZAMlS] was used as a host for 
plasmids. The following plasmids were used: 
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pMA102 [8], containing thepbpA and rodA genes; 
expression vector PIN-II-Al [lo], containing a 
strong Ipp-lac fused promoter (shown by a thick 
arrow in fig.1) and an lpp ribosome-binding site, 
followed by the initiation codon and cloning sites; 
puc13; and pUC4K [ 111, containing the 
kanamycin-resistance gene. The methods used for 
gene engineering were essentially the same as those 
described in [ 121. Restriction endonucleases and 
other modifying enzymes were standard commer- 
cial products. 
2.2. Oligonucleotide-directed site-specific 
mutagenesis 
A deletion was made by oligonucleotide-directed 
site-specific mutagenesis using double-stranded 
plasmid DNA, according to Morinaga et al. [ 131. 
The oligodeoxyribonucleotide, CGGCAGAGTC- 
CCGCTTTACCGA, used as a mutagenic primer 
was synthesized with a DNA synthesizer system 1 
plus (Beckman) and purified by reverse-phase 
high-performance liquid chromatography. [y- 
32P]ATP (-5000 ,&i/mmol, Amersham) was used 
for labeling the hybridization probe. DNA se- 
quencing was carried out by the dideoxy method 
using an Ml3 sequencing kit (Takara Shuzo Co.) 
and [a-32P]dCTP (-400 &i/mmol; Amersham). 
2.3. Growth and fractionation of cells 
E. coli MV1184 harboring a plasmid was grown 
in RH medium (15 g of Bactotryptone and 8 g of 
NaCl per liter, pH 7.0) with thiamine-HCI 
(1 pg/ml) at 37°C to the early logarithmic phase, 
and then expression was induced by the addition of 
IPTG to a final concentration of 1 mM. After in- 
duction for 3 h at 37”C, the cells were harvested. 
The periplasmic fraction was obtained by the cold 
osmotic shock method [ 141. Cells, after removal of 
the periplasmic fraction, were resuspended in ice 
cold 10 mM sodium phosphate buffer (pH 7.0) 
and then sonicated on ice. After removal of debris, 
the supernatant was centrifuged at 100000 x g for 
40 min at 4°C. The supernatant and precipitate 
thus obtained were termed the cytoplasmic and 
membrane fractions, respectively. The cyclic 
phosphodiesterase activity of each fraction was 
measured using bis(p-nitrophenyl)phosphate as a 
substrate [14]. The PBP assay was carried out us- 
ing [3H]benzylpenicillin (N-ethylpiperidinium salt) 
(16.4&i/$, 56.9&i/,ug; a gift from Dr P.J. 
Cassidy, Merck Sharp and Dohme, NJ, USA), as 
described [ 151. 
3. RESULTS 
Expression vectors for PBP2, pHA102 and 
pHA103, were constructed as shown in fig.1. The 
pbpA gene that encodes PBP2 can be transcribed 
under the control of the Ipp-fat fused promoter in 
the presence of the lac inducer, IPTG. These 
plasmids carry the kanamycin-resistance gene in- 
stead of the ampicillin-resistance gene. The N- 
terminal sequence of PBP2 encoded by the pbpA 
gene in pHA102 and pHA103 was a little different 
from that of the original PBP2 owing to a change 
in the N-terminal coding region; Met-Lys-Leu- 
Gln- changed to Met-Lys-Gly-Asn-Ser-. Both 
pHA102 and pHA103 complemented a pbpA 
mutant. 
The N-terminal hydrophobic region of PBP2 
contains a long stretch of 25 non-ionic amino acids 
(residues 21-45; average hydropathy, +2.1) [9] 
(fig.2). A deletion of 93 nucleotides encoding 31 
amino acids including the long stretch (residues 
15-45) (fig.2) was introduced into the pbpA gene 
of pHA102 by oligonucleotide-directed site- 
specific mutagenesis, and plasmid pHA102A93 
was obtained. Then, pHA103A93 was derived 
from pHA102A93 by removing the l.l-kb ApaI- 
BamHI fragment containing the rodA gene. The 
deletion was verified by DNA sequencing. The 
resulting N-terminal sequence of PBP2 is shown in 
fig.2, and we called the resulting protein, PBP2*. 
To determine the localization of PBP2*, IPTG- 
induced E. cofi cells harboring pHA103493 were 
separated into periplasmic, membrane and 
cytoplasmic fractions. The ratio of the relative ac- 
tivity of cyclic phosphodiesterase, a periplasmic 
enzyme, in each fraction obtained from the same 
amount of cells was 78:21: 1 (periplasmic/ 
cytoplasmic/membrane fractions, respectively), 
showing that the fractionation was good but not 
complete. The PBP assay results for each fraction, 
obtained from the same amount of cells, are shown 
in fig.3. PBP2* was overproduced and located on- 
ly in the cytoplasmic fraction (fig.3g), i.e., not in 
the membrane (fig.3h,l) and periplasmic (fig.3i) 
fractions. These results indicate that PBP2* re- 
mained in the cytoplasm in a water-soluble form 
and retained the penicillin-binding activity. The 
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Fig. 1. Construction of PBP2 expression vectors, pHA102 and pHA103. The pbpA gene was obtained from pMA102 
[8]. The F&I site, located immediately after the initiation codon of the p&,4 gene, was converted to an EcoRI site. 
The 3.2-kb EcoRI-BumHI fragment of pHAlO1 was inserted in frame between the EcoRI and BumHI sites, preceded 
by the initiation codon, of PINK-II-Al, which is a kanamycin-resistant derivative of an expression vector, PIN-II-Al 
[lo]. From the resulting plasmid, pHA102, the 1. I-kb A@-BumHI fragment containing the rodA region was removed, 
and pHA103 was obtained. 
production of PBP2* (fig.3g) was greater than that PBPZ": ~~GNSB---~YTAE~,~FTDYQ------AAAED~~ 
bf PBP2 expressed by-the &me promoter (fig.3e). 
The extents of overproduction of PBP2* (fig.3g) 
~$LFVRR$LVAFLGILLLTGVLIANLYNLQIV~ "5 
and PBP2 (fig.3e,k) relative to production of 
PBP2 in control cells were calculated to be about 
Fig.2. Amino acid sequence of PBP2* (upper line) and 
the removed N-terminal hydrophobic segment of PBP2 
500- and 300-fold, respectively. The calculation 
was carried out on the basis of the amounts of 
(residues 15-45) (lower line). Residues Leu-3-Gln-4 of 
PBP2 changed to Gly-Asn-Ser in PBP2*. 
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Fig.3. Detection of PBP2* in cytoplasmic (a,d,g), membrane (b,e,h,j-I) and periplasmic (c,f,i) fractions prepared from 
IPTG-induced E. coli cells of MVl184 (a-c,j), MVl184 (pHA103) (d-f,k) and MVl184 (pHA103493) (g-i,l). Each 
fraction (29~1) derived from cells corresponding to 0.53 (a-i) or 5.3 (j-l) A units at 660 nm was incubated at 30°C 
with 1 ~1 of [3H]benzylpenicillin (16.4 pCi/,& followed by separation by 10% SDS-polyacrylamide slab gel 
electrophoresis, and then PBPs were localized by fluorography. 
PBP2 and PBPS in control cells, 20 and 1800 
molecules/cell, respectively [ 161. 
4. DISCUSSION 
PBPs are considered to be ectoproteins [17], 
which are anchored to the cytoplasmic membrane 
by membrane-spanning segment(s), with a 
substantial portion of each protein protruding into 
the periplasmic space. PBPS, PBP6 (both D- 
alanine carboxypeptidases) [ 181 and PBP3 [ 191 
have N-terminal cleavable signal sequences that are 
essential for protein export, whereas the N- 
terminal sequence of PBP2 is not cleaved [9]. Our 
finding that PBP2* is localized in the cytoplasm in- 
dicates that the N-terminal hydrophobic region is 
an uncleaved signal peptide, and also suggests that 
the region anchors the protein to the cytoplasmic 
membrane. In contrast, the C-terminus of PBPS is 
essential for its localization to the cytoplasmic 
membrane [20]. 
Both pHA102A93 and pHA103493 were unable 
to complement a pbpA mutant (not shown), 
because of the localization of PBP2* in the 
cytoplasm. However, it is essential to determine 
whether or not PBP2* is able to catalyze both the 
transglycosylase and transpeptidase reactions by 
means of in vitro reconstitution experiments with 
the RodA protein. 
PBP2* could be purified from the soluble frac- 
tion of cells by affinity chromatography much 
more easily than membrane-bound PBP2, and was 
used to determine the penicillin-binding active site 
(Takasuga, A., Adachi, H., Ishino, F., Mat- 
suhashi, M., Ohta, T. and Matsuzawa, H., in 
preparation). The purified PBP2* is expected to be 
suitable for crystallization for X-ray studies on one 
of the penicillin-target enzymes. 
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